Online social media platforms (Meta (Facebook, Instagram, Google, Twitter)
London, United Kingdom
NCT Number: NCT05787652
Adults Regulating Their weight Everyday with Mobile Internet Support (ARTEMIS) is a randomised controlled trial evaluating the effectiveness of a mobile app based weight loss intervention designed to increase self-regulation in adults living with obesity.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
London, United Kingdom
Adults Regulating Their weight Everyday with Mobile Internet Support (ARTEMIS) is a randomised, controlled trial examining the effectiveness of the self-regulation intervention to promote weight loss, when delivered through a mobile application, with no in-person contact, among a sample of ~ 1,294 adults living with obesity in the United Kingdom. Further, the investigators will assess the safety of the intervention regarding any a potential unintended consequence, which is the development of disordered eating. The intervention comprises daily self-weighing and daily reflection on the day's task of controlling weight through implementation of actions, and selection of new actions for the next day. It encourages users to build up a repertoire of actions for life that suit them in controlling weight.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Participation is open to those who meet the following eligibility criteria:
Access to a self-regulation based mobile application.
Time frame: 6 months (baseline to 26-week follow up)
To assess if the intervention achieves significantly greater weight loss than the no-treatment control group.
Time frame: 6 months (baseline to 26-week follow up)
To assess if the intervention achieves significantly greater weight loss than the no-treatment control group.
Time frame: 12 weeks (baseline to 12-week follow up)
To assess if the intervention achieves significantly greater weight loss than the no-treatment control group in the short term.
Time frame: 12 weeks (baseline to 12-week follow up)
To assess if the intervention achieves significantly greater weight loss than the no-treatment control group in the short term.
Time frame: 12- and 26-week follow up (baseline to 12 and 26-week follow up)
To assess the impact of self-regulation intervention on disordered weight control. Note. the modified Eating Disorders Examination - Questionnaire Short Form (EDE-QS) has a maximum score of 18, with higher scores being indicative of disordered eating.
Time frame: 26 weeks
Process measure to assess whether the intervention engaged participants.
Time frame: 26 weeks
This is a process measure to assess whether the intervention engaged participants. This will be assessed as: 1. the total number of action plans completed; 2) the total number of action plans completed vs the total number of action plans selected, within the ARTEMIS app.
Time frame: 26 weeks
This is a process measure to assess whether the intervention engaged participants. This will be assessed as: 1. the total number of action plans completed; 2) the total number of action plans completed vs the total number of action plans selected, within the ARTEMIS app.
Time frame: 26 weeks
This is a process measure to assess whether the intervention engaged participants. This will be assessed as: 1. the total number of action plans completed; 2) the total number of action plans completed vs the total number of action plans selected, within the ARTEMIS app.
Time frame: 26 weeks
This is a process measure to assess whether the intervention engaged participants. This will be assessed as: 1. the total number of action plans completed; 2) the total number of action plans completed vs the total number of action plans selected, within the ARTEMIS app.
Time frame: 26 weeks
This is a process measure to assess whether the intervention engaged participants. This will be assessed as: 1. the total number of action plans completed; 2) the total number of action plans completed vs the total number of action plans selected, within the ARTEMIS app.
Time frame: 12 and 26 weeks
This is a process measure to assess whether the intervention led to participants taking action to manage their weight. This will be assessed using a purpose build questionnaire which asks participants "1.Have you taken any actions to manage your weight since the last assessment?". If Yes to question 1, this questionnaire further asks the following "2. What have you being doing to manage your weight (please click all that apply): Actively using the ARTEMIS app; using learned strategies from the ARTEMIS app, but not actively using app; using another online or app based weight loss programme; attending a weight loss programme where I see someone face-to-face; using weight loss medication; using a meal replacement programme; other (please specify further in the text box below).
Time frame: 26 weeks
This is a process measure to assess whether the intervention engaged participants. This will be recorded by participants entering free text into the app once prompted when they have indicated they have not completed their daily action plan i.e., "Please tell us why were you unable to perform your action yesterday? Is there anything you think would be useful to do differently next time you choose this action?". The investigators will use content analysis to analyse these data.
University of Oxford
Other
An Online Self-regulation Intervention to Support Weight Loss Among Adults Living With Obesity: a Randomised Controlled Trial
Acronym: ARTEMIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00739362
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsNCT05114798
Behavior, Body Weight
Chicago, Illinois, United States
View Trial DetailsNCT05713071
Body Weight, Body Weight Changes
Boston, Massachusetts, United States
View Trial DetailsNCT06945419
Body Weight, Body Weight Changes
Daytona Beach, Florida, United States
View Trial Details